thalidomide has been researched along with Zygomycosis in 1 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Zygomycosis: Infection in humans and animals caused by fungi in the class Zygomycetes. It includes MUCORMYCOSIS and entomophthoramycosis. The latter is a tropical infection of subcutaneous tissue or paranasal sinuses caused by fungi in the order Entomophthorales. Phycomycosis, closely related to zygomycosis, describes infection with members of Phycomycetes, an obsolete classification.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pulmonary zygomycosis is an uncommon infection that occurs mostly in immunocompromised patients." | 5.38 | Pulmonary zygomycosis in a non-neutropenic patient with myelodysplastic syndrome on lenalidomide. ( Akuthota, P; Kelly, E; Roberts, DH; Rosenthal, ES; Theisen-Toupal, J; Zwicker, JI, 2012) |
| "Pulmonary zygomycosis is an uncommon infection that occurs mostly in immunocompromised patients." | 1.38 | Pulmonary zygomycosis in a non-neutropenic patient with myelodysplastic syndrome on lenalidomide. ( Akuthota, P; Kelly, E; Roberts, DH; Rosenthal, ES; Theisen-Toupal, J; Zwicker, JI, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Theisen-Toupal, J | 1 |
| Rosenthal, ES | 1 |
| Kelly, E | 1 |
| Zwicker, JI | 1 |
| Akuthota, P | 1 |
| Roberts, DH | 1 |
1 other study available for thalidomide and Zygomycosis
| Article | Year |
|---|---|
Pulmonary zygomycosis in a non-neutropenic patient with myelodysplastic syndrome on lenalidomide.
Topics: Aged; Antineoplastic Agents; Fatal Outcome; Humans; Immunocompromised Host; Lenalidomide; Lung Disea | 2012 |